SB 2586·TN·senate
Health Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68.
Signed into LawFiled Feb 2, 2026
Sponsor: Jackson
Latest Action
Comp. became Pub. Ch. 1016
May 26, 2026
Topics
Track this bill
Get real-time alerts when SB 2586 changes status, plus AI-powered summaries and stage predictions.
Sign up free